- Home
- SMTI
SMTI
Sanara MedTech Inc.
as 11-08-2024 10:38am EST
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Upcoming Earnings Alert:
Get ready for potential market movements as Sanara MedTech Inc. SMTI prepares to release earnings report on 12 Nov 2024.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | FORT WORTH |
| Market Cap: | 288.2M | IPO Year: | N/A |
| Target Price: | $44.00 | AVG Volume (30 days): | 24.7K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $26.00 - $43.25 | Next Earning Date: | 11-12-2024 |
| Revenue: | $72,410,222 | Revenue Growth: | 21.42% |
| Revenue Growth (this year): | 26.97% | Revenue Growth (next year): | 18.91% |
Latest Sanara MedTech Inc. News
SMTI Breaking Stock News: Dive into SMTI Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership
GlobeNewswire
8 days ago
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
GlobeNewswire
a month ago
Sanara MedTech Inc. Announces Changes to Its Board of Directors
Simply Wall St.
a month ago
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years
GlobeNewswire
2 months ago
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
Simply Wall St.
3 months ago
Sanara MedTech Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GlobeNewswire
3 months ago
Sanara MedTech Inc. Announces Second Quarter 2024 Results
GlobeNewswire
3 months ago
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
Compare SMTI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SMTI Sanara MedTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.